Skip to main content

Acute Parkinsonism

  • Chapter
  • First Online:

Part of the book series: Current Clinical Neurology ((CCNEU))

Abstract

Acute onset parkinsonism is rare. The most common explanations are neuroleptic malignant syndrome, viral encephalitis, psychogenic, and catatonia. Testing, including cerebrospinal fluid analyses, toxicology, routine blood evaluations, imaging, and electroencephalograpy, assumes a much greater role than the evaluation of degenerative forms of parkinsonism. Acute parkinsonism should always be considered an emergency. Catatonia and neuroleptic malignant syndrome are treatable disorders that are often readily reversed. Viral encephalitis usually requires aggressive supportive care. Other, less common forms are also discussed in this chapter.

This chapter contains video segments that can be found on the accompanying DVD.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   159.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Friedman JH. Drug induced parkinsonism. In: Lang AE, Weiner WJ, editors. Drug-induced movement disorders. Mt Kisco: Futura Press; 1992. p. 41–84.

    Google Scholar 

  2. Fahn S, Przedborski S. Parkinsonism. In: Rowland LP, editor. Merritt’s textbook of neurology. 11th ed. Philadelphia: Lippincott Williams and Williams; 2005. p. 828–46.

    Google Scholar 

  3. Caligiuri MP, Ellwanger J. Motor and cognitive aspects of motor retardation in depression. J Affect Disord. 2000;47:83–93.

    Article  Google Scholar 

  4. Hymas N, Lees A, Bolton D, et al. The neurology of obsessional slowness. Brain. 1991;114:2203–33.

    Article  PubMed  Google Scholar 

  5. Curran T, Lang AE. Parkinsonian syndromes associated with hydrocephalus: case reports, a review of the literature and pathophysiological hypotheses. Mov Disord. 1994;9:508–20.

    Article  PubMed  CAS  Google Scholar 

  6. Sakurai T, Kimura A, Yamada M, et al. Rapidly progressive parkinsonism that developed one year after ventriculoperitoneal shunting for idiopathic aqueductal stenosis: a case report. Brain Nerve. 2010;62:527–31.

    PubMed  Google Scholar 

  7. Lees AJ. Secondary Parkinson’s syndrome. In: Jankovic JJ, Tolosa E, editors. Parkinson’s disease and movement disorders. 5th ed. Philadelphia: Lippincott Williams and Williams; 2007. p. 213–24.

    Google Scholar 

  8. Boecker H, Weindl A, Leenders K, et al. Secondary parkinsonism due to focal substantia nigra lesions: a PET study with (18F)FDG and (18F)fluorodopa. Acta Neurol Scand. 1996;93:387–92.

    Article  PubMed  CAS  Google Scholar 

  9. Stern G. The effects of lesions in the substantia nigra. Brain. 1966;89:449–78.

    Article  PubMed  CAS  Google Scholar 

  10. Hunter R, Smith J, Thomson T, Dayan AD. Hemiparkinsonism with infarction of the ilpsilateral substantia nigra. Neuropathol Appl Neurobiol. 1978;4:297–301.

    Article  PubMed  CAS  Google Scholar 

  11. Kim JS. Involuntary movements after anterior cerebral artery territory infarction. Stroke. 2001;32:258–61.

    Article  PubMed  CAS  Google Scholar 

  12. Nagaratnam N, Davies D, Chen E. Clinical effects of anterior cerebral artery infarction. J Stroke Cerebrovasc Dis. 1998;7:391–7.

    Article  PubMed  CAS  Google Scholar 

  13. Dick JP, Benecke R, Rothwell JC, et al. Simple and complex movements in a patient with infarction of the right supplementary motor area. Mov Disord. 1986;1:255–66.

    Article  PubMed  CAS  Google Scholar 

  14. Russmann H, Vingerhoets F, Ghika J, et al. Acute infarction limited to the lenticular nucleus: clinical, etiologic and topographic features. Arch Neurol. 2003;60:351–8.

    Article  PubMed  Google Scholar 

  15. Turjanski N, Pentland B, Lees AJ, Brooks DJ. Parkinsonism associated with acute intracranial hematomas: an (18F)Dopa positron-emission tomography study. Mov Disord. 1997;12: 1035–8.

    Article  PubMed  CAS  Google Scholar 

  16. Orta Daniel SJ, Ulises RO. Stroke of the substantia nigra and parkinsonism as the first manifestation of systemic lupus erythematosis. Parkinsonism Relat Disord. 2008;14:367–9.

    Article  PubMed  Google Scholar 

  17. Wang JD, Huang CC, Hwang YH, et al. Manganese induced parkinsonism: an outbreak due to an unrepaired ventilation control system in a ferromanganese smelter. Br J Ind Med. 1989;46:856–9.

    PubMed  CAS  Google Scholar 

  18. Feldman RG. Manganese. In: Occupational and environmental medicine. Philadelphia: Lippincott Raven Press; 1999. p. 168–188.

    Google Scholar 

  19. Sohn YH, Jeong Y, Kim HS, Im JH, Kim JS. The brain lesion responsible for parkinsonism after carbon monoxide poisoning. Arch Neurol. 2000;57:1214–8.

    Article  PubMed  CAS  Google Scholar 

  20. Perry GF. Occupational medicine forum. What are the potential delayed health effects of high level carbon monoxide exposure? J Occup Med. 1994;36:595–7.

    Google Scholar 

  21. Shprecher D, Mehta L. The syndrome of delayed post-hypoxic leukoencephalopathy. NeuroRehabilitation. 2010;26:65–72.

    PubMed  Google Scholar 

  22. Okuda B, Iwamoto Y, Tachibana H, Sugita M. Parkinsonism after acute cadmium poisoning. Clin Neurol Neurosurg. 1997;99:263–5.

    Article  PubMed  CAS  Google Scholar 

  23. Barbosa ER, Comerlatti LR, Haddad MS, Scaff M. Parkinsonism secondary to ethylene oxide exposure: case report. Arq Neurosiquiatr. 1992;50:531–3.

    Article  CAS  Google Scholar 

  24. Laplane D, Attal N, Sauron B, et al. Lesions of the basal ganglia due to disulfiram neurotoxicity. J Neurol Neurosurg Psychiatry. 1992;44:925–9.

    Article  Google Scholar 

  25. Messing B. Extrapyramidal disturbance after cyanide poisoning. J Neural Transm Suppl. 1991;33:141–7.

    PubMed  CAS  Google Scholar 

  26. Pentore R, Venneri A, Nichelli P. Accidental choke-cherry poisoning: early symptoms and neurological sequelae of an unusual case of cyanide intoxication. Ital J Neurol Sci. 1996;17:233–5.

    Article  PubMed  CAS  Google Scholar 

  27. Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic parkinsonism in humans due to a product of meperidine analogue synthesis. Science. 1983;219:979–80.

    Article  PubMed  CAS  Google Scholar 

  28. Leopold NA, Bara-Jimenez W, Hallett M. Parkinsonism after a wasp sting. Mov Disord. 1999;14:122–7.

    Article  PubMed  CAS  Google Scholar 

  29. Agarwal V, Singh R, Chauhau S, J’Cruz S, Thakur R. Parkinsonism following a honey bee sting. Indian J Med Sci. 2006;60:24–5.

    Article  PubMed  Google Scholar 

  30. Bogolepov NK, Luzhetskaya TA, Fedin AI, et al. Allergic encephalomyelopolyradiculoneuritis from a wasp sting (clinico-patholo report). Zh Nevropatol Psikhiatr Im SS Korsakova. 1978;78:187–91.

    CAS  Google Scholar 

  31. Shandling M, Carlen PL, Lang AE. Parkinsonism in alcohol withdrawal: a follow-up study. Mov Disord. 1990;4:36–9.

    Article  Google Scholar 

  32. Carlen PL, Lee MA, Jacob M, Livishitz O. Parkinsonism provoked by alcoholism. Ann Neurol. 1981;9:84–6.

    Article  PubMed  CAS  Google Scholar 

  33. Lang AE, Marsden CD, Obeso JA, Parkes JD. Alcohol and Parkinson disease. Ann Neurol. 1982;12:254–6.

    Article  PubMed  CAS  Google Scholar 

  34. San Luciano M, Saunders-Pullman R. Substance abuse and movement disorders. Curr Drug Abuse Rev. 2009;2:273–8.

    Article  PubMed  CAS  Google Scholar 

  35. Tinker R, Anderson MG, Anand P, et al. Pontine myelinolysis presenting with acute parkinsonism as a sequel of corrected hyponatremia. J Neurol Neurosurg Psychiatry. 1990;53:87–9.

    Article  PubMed  CAS  Google Scholar 

  36. Dickoff DJ, Rapps M, Yahr MD. Striatal syndrome following hyponatremia and its rapid correction. Arch Neurol. 1988;45:112–4.

    Article  PubMed  CAS  Google Scholar 

  37. Bernardini GL, Mancall EL. Central pontine myelinolysis. In: Rowland LP, editor. Merritt’s neurology. 11th ed. Philadelphia: Lippincott Williams and Wilins; 2005. p. 965–7.

    Google Scholar 

  38. Hawker K, Lang AE. Hypoxic-ischemic damage of the basal ganglia: case reports and a review of the literature. Mov Disord. 1990;5:219–24.

    Article  PubMed  CAS  Google Scholar 

  39. Straussberg R, Shahar E, Gat R, Brand N. Delayed parkinsonism associated with hypotension in a child undergoing open-heart surgery. Dev Med Child Neurol. 1993;35:1007–14.

    Google Scholar 

  40. Li JY, Lai PH, Chen CY, et al. Postanoxic parkinsonism: clinical radiologic and pathologic correlation. Neurology. 2000;55:591–3.

    Article  PubMed  CAS  Google Scholar 

  41. Gillman PK. Neuroleptic malignant syndrome: mechanisms, interactions and causality. Mov Disord. 2010;25:1780–90.

    Article  PubMed  Google Scholar 

  42. Carbone JR. The neuroleptic malignant syndrome and serotonin syndromes. Emerg Clin North Am. 2000;18:317–25.

    Article  CAS  Google Scholar 

  43. Susman VL. Clinical management of neuroleptic malignant syndrome. Psychiatr Q. 2001;72:325–6.

    Article  PubMed  CAS  Google Scholar 

  44. Perrin E, Anand E, Dyachkova Y, et al. A prospective observational study of the safety and effectiveness of intramuscular psychotropic treatment in acutely agitated patients with schizophrenia and bipolar mania. Eur Psychiatry. 2012;27(4):234–9.

    Article  PubMed  CAS  Google Scholar 

  45. Lockman LA, Sung JH, Krivit W. Acute parkinsonian syndrome with demyelinating leukoencephalopathy in bone marrrow transplant recipients. Pediatr Neurol. 1991;7:457–63.

    Article  PubMed  CAS  Google Scholar 

  46. Devinsky O, Lemann W, Evans AC, et al. Akinetic mutism in a bone marrow transplant recipient following total-body irradiation and amphotericin B chemoprophylaxis: a positron emission tomographic and neuropathologic study. Arch Neurol. 1987;44:414–7.

    Article  PubMed  CAS  Google Scholar 

  47. Chuang C, Constantino A, Balmaceda C, et al. Chemotherapy-induced parkinsonism responsive to levodopa: an under-recognized entity? Mov Disord. 2003;18:328–31.

    Article  PubMed  Google Scholar 

  48. Lima MA, Maradei S, Maranhao Filho P. Cyclosporin-induced parkinsonism. J Neurol. 2009;245:674–5.

    Article  Google Scholar 

  49. Shahar E, Goshen E, Tauber Z, Lahat E. Parkinsonian syndrome complicating systemic lupus erythematosus. Pediatr Neurol. 1998;18:456–8.

    Article  PubMed  CAS  Google Scholar 

  50. Yancey CL, Doughty RA, Athreya BH. Central nervous system involvement in childhood system lupus erythematosis. Arthritis Rheum. 1981;24:1389–95.

    Article  PubMed  CAS  Google Scholar 

  51. Francis A. Catatonia: diagnosis, classification and treatments. Curr Psychiatry Rep. 2010;12:180–5.

    Article  PubMed  Google Scholar 

  52. Friedman JH. Stereotypy and catatonia. In: Jankovic JJ, Tolosa E, editors. Parkinson’s disease and movement disorders. 5th ed. Baltimore, MD, USA: Williams and Wilkins; 2007. p. 468–80.

    Google Scholar 

  53. Bush G, Fink M, Petrides G, et al. Catatonia: 2. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand. 1996;93:137–43.

    Article  PubMed  CAS  Google Scholar 

  54. Factor SA, Podskalny GD, Molho ES. Psychogenic movement disorders: frequency, clinical profile and characteristics. J Neurol Neurosurg Psychiatry. 1994;59:406–12.

    Article  Google Scholar 

  55. Trimble MR. Clinical presentations in neuropsychiatry. Semin Clin Neuropsychiatry. 2002;7:11–7.

    Article  PubMed  Google Scholar 

  56. Lang AE, Koller WC, Fahn S. Psychogenic parkinsonism. Arch Neurol. 1995;52:802–10.

    Article  PubMed  CAS  Google Scholar 

  57. Koller WC, Findley LI. Psychogenic tremors. Adv Neurol. 1990;53:271–5.

    PubMed  CAS  Google Scholar 

  58. Von Economo C. Encephalitis lethargica. Wien Klin Wochenschr. 1917;30:581–5.

    Google Scholar 

  59. Urechia CL. Dix cas d’encephalite epidemique avec autopsie. Arch Inter Neurol. 1921;2:65–78.

    Google Scholar 

  60. Cruchet R, Moutier F, Calmette A. Quarante cas d’encephalo-myelite subaigue. Bull Mem Soc Med d’Hop. 1917;41:614–6.

    Google Scholar 

  61. Etienne G. Myelities aigues epidemiques. Deux épidémies militares. Rev Neurol. 1917;24:375–6.

    Google Scholar 

  62. Watson AJ. Origin of encephalitis lethargica. Chin Med J. 1928;42:427–32.

    Google Scholar 

  63. Von Economo C. Encephalitis lethargica: its sequelae and treatment (translated by K.O. Newman). London: Oxford University Press; 1931. p. I–XIV. 1–200.

    Google Scholar 

  64. Duvoisin RC, Yahr MD. Encephalitis and parkinsonism. Arch Neurol. 1965;12:227–39.

    Article  PubMed  CAS  Google Scholar 

  65. Geddes JF, Hughes AJ, Lees AJ, Daniel SE. Pathological overlap in cases of parkinsonism associated with neurofibrillary tangles. Brain. 1993;116:281–2.

    Article  PubMed  Google Scholar 

  66. Wilson SAK. Epidemic encephalitis. In: Neurology. Volume 1. Baltimore: Williams and Wilkins C; 1940. p. 118–65.

    Google Scholar 

  67. Morrison PJ, Patterson VH. Cranial dystonia (Meige syndrome) in postencephalitic parkinsonism. Mov Disord. 1992;7:90–1.

    Article  PubMed  CAS  Google Scholar 

  68. Wenning GK, Jellinger K, Litvan I. Supranuclear gaze palsy and eyelid apraxia in postencephalitic parkinsonism. J Neural Transm. 1997;104:845–65.

    Article  PubMed  CAS  Google Scholar 

  69. Litvan I, Jankovic J, Goetz CG. Accuracy of the clinical diagnosis of postencephalitic parkinsonism: a clinicopathologic study. Eur J Neurol. 1998;5:451–7.

    Article  PubMed  Google Scholar 

  70. Vilensky JA, Gilman S, McCall S. A historical analysis of the relationship between encephalitis lethargica and post-encephalitic parkinsonism: a complex rather than a direct relationship. Mov Disord. 2010;25:116–23.

    Google Scholar 

  71. Duncan AG. The sequelae of encephalitis lethargica. Brain. 1924;47:76–108.

    Article  Google Scholar 

  72. Calne DB, Lees AJ. Late progression of post-encephalitic Parkinson syndrome. Can J Neurol Sci. 1988;15:135–8.

    PubMed  CAS  Google Scholar 

  73. Vieregge P, Reinhardt V, Hoft B. Is progression in postencephalitic Parkinson’s disease late and age-related? J Neurol. 1991;238:299–303.

    PubMed  CAS  Google Scholar 

  74. Ravenholt RT, Foege WH. 1918 Influenza, encephalitis lethargica, parkinsonism. Lancet. 1982;2:860–2.

    Article  PubMed  CAS  Google Scholar 

  75. Laidlaw PP. Epidemic influenza: a virus disease. Lancet. 1935;1:1118–24.

    Article  Google Scholar 

  76. Casals J, Elizan TS, Yahr MD. Postencephalitic parkinsonism—a review. J Neural Transm. 1998;105:645–76.

    Article  PubMed  CAS  Google Scholar 

  77. Gamboa ET, Wolf A, Yahr MD, et al. Influenza virus antigen in postencephalitic parkinsonism brain. Arch Neurol. 1974;31:228–32.

    Article  PubMed  CAS  Google Scholar 

  78. Martilla RJ, Halomen P, Rinne UK. Influenza virus antibodies in parkinsonism. Comparison of postencephalitic and idiopathic Parkinson patients and matched controls. Arch Neurol. 1977;34:99–100.

    Article  Google Scholar 

  79. Elizan T, Schwartz J, Yahr MD, Casals J. Antibodies against arboviruses in postencephalitic and idiopathic Parkinson’s disease. Arch Neurol. 1978;35:257–60.

    Article  PubMed  CAS  Google Scholar 

  80. Takahashi M, Yamada T, Nakajima S, et al. The substantia nigra is a major target for neurovirulent influenza A virus. J Exp Med. 1995;181:2161–9.

    Article  PubMed  CAS  Google Scholar 

  81. Elizan TS, Casals J, Yahr MD. Antineurofilament antibodies in postencephalitic and idiopathic Parkinson’s disease. J Neurol Sci. 1983;59:341–7.

    Article  PubMed  CAS  Google Scholar 

  82. Elizan TS, Yahr MD. Histocompatibility antigens and postencephalitic parkinsonism. J Neurol Neurosurg Psychiatry. 1983;46:688–93.

    Article  PubMed  CAS  Google Scholar 

  83. Lees AJ, Stern GM, Compston DAS. Histocompatibility antigens and post-encephalitic parkinsonism. J Neurol Neurosurg Psychiatry. 1982;45:1060–1.

    Article  PubMed  CAS  Google Scholar 

  84. Williams A, Houff S, Lees A, Calne DB. Oligoclonal banding in the cerebrospinal fluid of patients with postencephalitic parkinsonism. J Neurol Neurosurg Psychiatry. 1979;42:790–2.

    Article  PubMed  CAS  Google Scholar 

  85. Rail D, Scholtz C, Swash M. Postencephalitic parkinsonism: current experience. J Neurol Neurosurg Psychiatry. 1981;44:670–6.

    Article  PubMed  CAS  Google Scholar 

  86. Clough CG, Plaitakis A, Yahr MD. Oculogyric crises and parkinsonism: a case of recent onset. Arch Neurol. 1983;40:36–7.

    Article  PubMed  CAS  Google Scholar 

  87. Johnson J, Lucey PA. Encephalitis lethargica, a contemporary cause of catatonic stupor: a report of two cases. Br J Psychiatry. 1987;151:550–2.

    Article  PubMed  CAS  Google Scholar 

  88. Howard RS, Lees AJ. Encephalitis lethargica. A report of four recent cases. Brain. 1987;110:19–33.

    Article  PubMed  Google Scholar 

  89. Misra UK, Kalita J. Spectrum of movement disorders in encephalitis. J Neurol. 2010;257: 2052–8.

    Article  PubMed  CAS  Google Scholar 

  90. Ghaemi M, Rudolf S, Schmulling S, Bamborschke S, Heiss WD. FDG- and Dopa-PET in postencephalitic parkinsonism. J Neural Transm. 2000;107:1289–95.

    Article  PubMed  CAS  Google Scholar 

  91. Cree BC, Bernardini GL, Hays AP, Lowe G. A fatal case of coxackievirus B4 meningoencephalitis. Arch Neurol. 2003;60:107–8.

    Article  PubMed  Google Scholar 

  92. Nath A, Jankovic J, Pettigrew LC. Movement disorders and AIDS. Neurology. 1987;37:37–41.

    Article  PubMed  CAS  Google Scholar 

  93. Carranzana EJ, Rossitch E, Samuels MA. Parkinsonian symptoms in a patient with AIDS and cerebral toxoplasmosis. J Neurol Neurosurg Psychiatry. 1989;12:1445–7.

    Article  Google Scholar 

  94. Navia BA, Petito CK, Gold JWM, et al. Cerebral toxoplasmosis complicating the acquired immunodeficiency syndrome: clinical and neuropathological findings in 27 patients. Ann Neurol. 1986;19:224–38.

    Article  PubMed  CAS  Google Scholar 

  95. Noel S, Gaillaume MP, Telerman-Toppet N, et al. Movement disorders due to cerebral Toxoplasma gondii infection in patients with the acquired immunodeficiency syndrome (AIDS). Acta Neurol Belg. 1992;92:148–56.

    PubMed  CAS  Google Scholar 

  96. Maggi P, de Mari M, Moramarco A, Fiorentino P, Lamberti P, Angarano G. Parkinsonism in a patient with AIDS and cerebral opportunistic granulomatous lesions. Neurol Sci. 2002;21:173–6.

    Article  Google Scholar 

  97. De Mattos JP, Rosso AL, Correa RD, et al. Involuntary movements and AIDS: report of seven cases and review of the literature. Arq Neuropsiquiatr. 1993;51:491–7.

    Article  PubMed  Google Scholar 

  98. Misattari SM, Power C, Nath A. Parkinsonism with HIV infection. Mov Disord. 1998;13:684–9.

    Article  Google Scholar 

  99. Cardoso F. HIV-related movement disorders: epidemiology, pathogenesis and management. CNS Drugs. 2002;16:663–8.

    Article  PubMed  Google Scholar 

  100. Sandyk R. Parkinsonism secondary to neurosyphilis: a case report. S Afr Med J. 1983;23:665–6.

    Google Scholar 

  101. Garcia-Moreno JM, Izquierdo G, Chacon J, Angulo S, Borobio MV. Neuroborreliosis in a patient with progressive supranuclear paralysis: an association or a cause? Rev Neurol. 1997;25:1919–21.

    PubMed  CAS  Google Scholar 

  102. Zambrino CA, Zorzi G, Lanzi G, Uggetti C, Egitto MC. Bilateral striatal necrosis associated with mycoplasma pnuemoniae infection in an adolescent: clinical and neurodiagnostic follow-up. Mov Disord. 2000;15:1023–6.

    Article  PubMed  CAS  Google Scholar 

  103. Al-Mateen M, Gibbs M, Dietrch R, Mitchell WG, Menkes JH. Encephalitis lethargica-like illness in a girl with mycoplasma infection. Neurology. 1988;38:1155–8.

    Article  PubMed  CAS  Google Scholar 

  104. Saitoh S, Wada T, Narita M, et al. Mycoplasma pneumoniae infection may cause striatal lesions leading to acute neurological dysfunction. Neurology. 1993;43:2150–1.

    Article  PubMed  CAS  Google Scholar 

  105. Kim JS, Choi IS, Lee MC. Reversible parkinsonism and dystonia following probable mycoplasma pneumoniae infection. Mov Disord. 1995;10:510–2.

    Article  PubMed  CAS  Google Scholar 

  106. Brandel J, Noseda G, Agid Y. Mycoplasma pneumoniae postinfectious encephalomyelitis with bilateral striatal necrosis. Mov Disord. 1996;11:333–5.

    Article  PubMed  CAS  Google Scholar 

  107. Singer C, Berger JR, Bowen BC, Bruce JH, Weiner WJ. Akinetic-rigid syndrome in a 13-year old girl with HIV-related progressive multifocal leukoencephalopathy. Mov Disord. 1993;8:113–6.

    Article  PubMed  CAS  Google Scholar 

  108. Werring DJ, Chaudhuri KR. HIV-related progressive multifocal leukoencephalopathy presenting with an akinetic-rigid syndrome. Mov Disord. 1996;11:758–61.

    Article  PubMed  CAS  Google Scholar 

  109. De la Fuente J, Bordon J, Moreno JA, et al. Parkinsonism in an HIV-infected patient with hypodense cerebral lesion. Tuber Lung Dis. 1996;77:191–2.

    Article  Google Scholar 

  110. Strong G. Parkinson’s syndrome following herpes ophthalmicus. Br Med J. 1952;1:533.

    Article  PubMed  CAS  Google Scholar 

  111. Fenichel GM. Postvaccinal parkinsonism. Mov Disord. 1993;8:253.

    PubMed  CAS  Google Scholar 

  112. Reijneveld JC, Taphoorn MJB, Hoogenraad TU, Van Gijn J. Severe but transient parkinsonism after tetanus vaccination. J Neurol Neurosurg Psychiatry. 1997;63:258–9.

    Article  PubMed  CAS  Google Scholar 

  113. McCall S, Henry JM, Reid AH, Taubenberger JK. Influenza RNA not detected in archival brain tissues from acute encephalitis lethargica cases or in postencephalitic parkinson cases. J Neuropathol Exp Neurol. 2001;60:696–704.

    PubMed  CAS  Google Scholar 

  114. Krusz JC, Koller WC, Ziegler DK. Historical review: abnormal movements associated with epidemic encephalitis lethargica. Mov Disord. 1987;2:137–41.

    Article  PubMed  CAS  Google Scholar 

  115. Elizan TS, Casals J. Astrogliosis in von Economo’s and postencephalitic Parkinson’s diseases supports probable viral etiology. J Neurol Sci. 1991;105:131–4.

    Article  PubMed  CAS  Google Scholar 

  116. Hof PR, Charpiot A, Delacourte A, et al. Distribution of neurofibrillary tangles and senile plaques in the cerebral cortex in postencephalitic parkinsonism. Neurosci Lett. 1992;139:10–4.

    Article  PubMed  CAS  Google Scholar 

  117. Josephs KA, Parisi JE, Dickson DW. Alpha-synuclein studies are negative in postencephalitic parkinsonism of von Economo. Neurology. 2002;59:645–6.

    Article  PubMed  Google Scholar 

  118. Ikeda K, Akiyama H, Kondo H, Ikeda K. Anti-tau-positive glial fibrillary tangles in the brain of post-encephalitic parkinsonism of Economo type. Neurosci Lett. 1993;162(1–2):176–8.

    Google Scholar 

  119. Wong KT, Allen IV, McQuaid S, McConnell R. An immunohistochemical study of neurofibrillary tangle formation in post-encephalitic parkinsonism. Clin Neuropathol. 1996;15:22–5.

    PubMed  CAS  Google Scholar 

  120. Shen WC, Ho YJ, Lee SK, Lee KR. MRI of transient post-encephalitic parkinsonism. J Comput Assist Tomogr. 1994;18:155–9.

    Article  PubMed  CAS  Google Scholar 

  121. Caparros-Lefebvre D, Cabaret M, Godefroy O, et al. PET study and neuropsychological assessment of a long-lasting post-encephalitic parkinsonism. J Neural Transm. 1998;105:489–95.

    Article  PubMed  CAS  Google Scholar 

  122. Solbrig MV, Nashef L. Acute parkinsonism in suspected herpes simplex encephalitis. Mov Disord. 1993;8:233–4.

    Article  PubMed  CAS  Google Scholar 

  123. Savant CS, Singhal BS, Jankovic J, Khan MAK, Virani A. Substantia nigra lesions in viral encephalitis. Mov Disord. 2003;18:213–27.

    Article  PubMed  Google Scholar 

  124. Alves RSC, Barbosa ER, Scaff M. Postvaccinal parkinsonism. Mov Disord. 1992;7:178–80.

    Article  PubMed  CAS  Google Scholar 

  125. Calne DB, Stern GM, Laurence DR. L-dopa in postencephalitic parkinsonism. Lancet. 1969;1:744–6.

    Article  PubMed  CAS  Google Scholar 

  126. Sacks O. Awakenings. New York: Harper Perennial; 1990.

    Google Scholar 

  127. Duvoisin RC, Lobo-Antunes J, Yahr MD. Response of patients with post-encephalitic parkinsonism to levodopa. J Neurol Neurosurg Psychiatry. 1972;35:487–95.

    Article  PubMed  CAS  Google Scholar 

  128. Walters JH. Postencephalitic parkinson syndrome after meningoencephalitis due to coxackie virus group B, type 2. N Engl J Med. 1960;263:744–7.

    Article  Google Scholar 

  129. Posner CM, Huntley CJ, Poland JD. Para-encephalitic parkinsonism. Acta Neurol Scand. 1969;45:199–215.

    Article  Google Scholar 

  130. Giraldi C, Mazzoni M, Morgantini PG, Lunardi CV. Parkinsonian syndrome during viral encephalitis. Riv Neurol. 1991;61:183–5.

    PubMed  CAS  Google Scholar 

  131. Ickenstein GW, Klotz JM, Langorh HD. Virus encephalitis with symptomatic parkinsonian syndrome, diabetes insipidus and panhypopituitarism. Fortschr Neurol Psychiatr. 1999;67: 476–81.

    Article  PubMed  CAS  Google Scholar 

  132. Hsieh JC, Lue KH, Lee YL. Parkinson-like syndrome as the major presenting symptom of Epstein-Barr virus encephalitis. Arch Dis Child. 2002;87:358–9.

    Article  PubMed  Google Scholar 

  133. Isgreen WP, Chutarian AM, Fahn S. Sequential parkinsonism and chorea following “mild” influenza. Trans Am Neurol Assoc. 1976;101:56–9.

    PubMed  CAS  Google Scholar 

  134. Shiraki H, Goto A, Narabayashi H. Etat passe et present de l’encephalite Japonnaise au Japon. Rev Neurol (Paris). 1963;108:633–96.

    CAS  Google Scholar 

  135. Ishii T, Marsushita M, Hamada S. Characteristic residual neuropathological features of Japanese B encephalitis. Acta Neuropathol (Berl). 1977;38:181–6.

    Article  CAS  Google Scholar 

  136. Shoji H, Watanabe M, Itoh S, Kuwahara H, Hattori F. Japanese encephalitis and parkinsonism. J Neurol. 1993;240:59–60.

    Article  PubMed  CAS  Google Scholar 

  137. Pradham S, Pandey N, Shashank S, et al. Parkinsonism due to predominant involvement of the substantia nigra in Japanese encephalitis. Neurology. 1999;53:1781–6.

    Article  Google Scholar 

  138. Scheid W, Ackerman R, Felgenhauer K. Lymphozytare choriomeningitis unter dem bild der Encephalitis lethargica. Dtsch Med Wochenschr. 1968;93:940–3.

    Article  PubMed  CAS  Google Scholar 

  139. Adair CV, Gould RL, Smadel JE. Aseptic meningitis, a disease of diverse etiology: clinical and etiological studies of 854 cases. Ann Intern Med. 1953;39:675–704.

    PubMed  CAS  Google Scholar 

  140. Bennett NMcK. Murray Valley encephalitis, 1947: clinical features. Med J Aust. 1976;2:446–50.

    PubMed  CAS  Google Scholar 

  141. Bickerstaff ER, Cloake PCP. Mesencephalitis and rhombencephalitis. Br Med J. 1951;2:77–81.

    Article  PubMed  CAS  Google Scholar 

  142. Thieffrey S. Enterovirus et maladies du systeme nerveux: revisiou critique et experience personnelle. Rev Neurol (Paris). 1963;108:753–76.

    Google Scholar 

  143. Barrett AM, Gairdner D, McFarlan AM. An outbreak of encephalitis possibly due to poliomyitis virus. Br Med J. 1952;1:1317–22.

    Article  PubMed  CAS  Google Scholar 

  144. Vincent FM, Myers WG. Poliomyelitis and parkinsonism. N Engl J Med. 1978;298:688–9.

    Article  PubMed  CAS  Google Scholar 

  145. Mellon AF, Appleton RE, Gardner-Medwin D, Aynsley-Green A. Encephalitis lethargica-like illness in a 5 year old. Dev Med Child Neurol. 1991;33:153–6.

    Google Scholar 

  146. Meyer B. Encephalitis after measles with severe parkinsonian rigidity: recovery. Br Med J. 1943;1:508.

    Article  PubMed  CAS  Google Scholar 

  147. Henner K, Hanzal F. Encephalite tchecoslavaque a tiques. Rev Neurol (Paris). 1957;96:384–408.

    CAS  Google Scholar 

  148. Henner K, Hanzal F. Les encephalities europeenes a tiques. Rev Neurol (Paris). 1963;108:697–752.

    CAS  Google Scholar 

  149. Radsel-Melvescek A, Marolt-Gomiscek M, Pouse-Trojar M, Gajsek-Zima M. Late sequelae after tick-borne meningoencephalitis in patients treated at the hospital for infectious diseases at University Medical Centre of Ljubljana during the period 1974–1975. Zentralbl Bakteriol. 1980;9(suppl):281–4.

    Google Scholar 

  150. Cerna F, Mehrad B, JP Luby, et al. St. Louis encephalitis and the substantia nigra: MR imaging evaluation. Am J Neuroradiol. 1999;20:1281–3.

    PubMed  CAS  Google Scholar 

  151. Wasay M, Diaz-Arastia R, Suss R, et al. St. Louis encephalitis: a review of 11 cases in a 1995 Dallas, Texas epidemic. Arch Neurol. 2000;57:114–8.

    Article  PubMed  CAS  Google Scholar 

  152. Finley KH. Postencephalitic manifestations of viral encephalitides. In: Fields WS, Blattner RJ, editors. Viral encephalitis. Springfield Ill: CC Thomas; 1958. p. 69–94.

    Google Scholar 

  153. Finley KH, Riggs N. Convalescence and sequelae. In: Monath TP, editor. St. Louis encephalitis. Washington DC: Am Pub Hlth Assoc; 1980. p. 535–50.

    Google Scholar 

  154. Fulton JC, Burton AN. After effects of WEE infection in man. Canad MAJ. 1953;69: 268–72.

    CAS  Google Scholar 

  155. Mulder DW, Parrot M, Thaler M. Sequelae of western equine encephalitis. Neurology. 1951;1:318–27.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hubert H. Fernandez M.D. .

Editor information

Editors and Affiliations

Electronic Supplementary Material

Movement_Disorders_Emergencies_C2.mov (54,258) KB

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Fernandez, H.H., Friedman, J.H. (2013). Acute Parkinsonism. In: Frucht, S. (eds) Movement Disorder Emergencies. Current Clinical Neurology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-835-5_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-835-5_2

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60761-834-8

  • Online ISBN: 978-1-60761-835-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics